Virtus ETF Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $303K | Sell |
|
|||||
|
2024
Q3 | $1.15M | Sell |
|
|||||
|
2024
Q2 | $1.31M | Buy |
|
|||||
|
2024
Q1 | $1.11M | Buy |
|
|||||
|
2023
Q4 | $974K | Sell |
|
|||||
|
2023
Q3 | $1.03M | Sell |
|
|||||
|
2023
Q2 | $1.18M | Sell |
|
|||||
|
2023
Q1 | $1.21M | Buy |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | $969K | Sell |
|
|||||
|
2022
Q2 | $1.02M | Buy |
|
|||||
|
2022
Q1 | $464K | Hold |
|
|||||
|
2021
Q4 | $390K | Sell |
|
|||||
|
2021
Q3 | $426K | Sell |
|
|||||
|
2021
Q2 | $517K | Sell |
|
|||||
|
2021
Q1 | $589K | Buy |
|
|||||
|
2020
Q4 | $631K | Buy |
|
|||||
|
2020
Q3 | $592K | Sell |
|
|||||
|
2020
Q2 | $633K | Sell |
|
|||||
|
2020
Q1 | $638K | Sell |
|
|||||
|
2019
Q4 | $637K | Sell |
|
|||||
|
2019
Q3 | $689K | Sell |
|
|||||
|
2019
Q2 | $872K | Buy |
|
|||||
|
2019
Q1 | $814K | Buy |
|
|||||
|
2018
Q4 | $586K | Sell |
|
|||||
|
2018
Q3 | $974K | Buy |
|
|||||
|
2018
Q2 | $801K | Sell |
|
|||||
|
2018
Q1 | $1.03M | Sell |
|
|||||
|
2017
Q4 | $1.02M | Sell |
|
|||||
|
2017
Q3 | $1.26M | Hold |
|
|||||
|
2017
Q2 | $1.07M | Sell |
|
|||||
|
2017
Q1 | $1.45M | Buy |
|
|||||
|
2016
Q4 | $880K | Buy |
|
|||||
|
2016
Q3 | $594K | Buy |
|
|||||
|
2016
Q2 | $512K | Buy |
|
|||||
|
2016
Q1 | $400K | Buy |
|